MPN Clinical Trials Center

What is a clinical trial? What are the phases of clinical trials? What are the latest MPN clinical trials? Patient Power helps you understand clinical trials, how these studies benefit research for MPNs, and why you should consider participating.  Below are some of our most recent programs discussing clinical trials. 

Searching for Available MPN Clinical Trials?  Use our clinical trial finder to find trials near you, here.

Awareness: Making a Difference Through MPN Clinical Trials

A panel of MPN experts and advocates discuss available resources for patients, including clinical trials and MPN Research Foundation.


Expert Perspective: Advancing MPN Treatment Through Education and Clinical Trials

Dr. John Mascarenhas from Mount Sinai School of Medicine shares his expert opinion on current MPN laboratory and clinical research, and how this information can be optimized by both patients and providers.


Clinical Trials for Combination Therapies in MPNs

Dr. Claire Harrison from the Guy's and St. Thomas’ Hospital in London, joined Patient Power to discuss combination therapies for the treatment of myeloproliferative neoplasms (MPNs).


Polycythemia Vera: What Researchers Are Learning From an Observational Study

As part of our coverage of the 2015 American Society of Hematology (ASH) annual meeting, Carol Preston speaks with Dr. Brady Stein about the observational study for patients with polycythemia vera (PV), the REVEAL study.


ASH 2015 Coverage: MPN Research Updates From a Panel of Experts

As part of our coverage from the 2015 American Society of Hematology (ASH), MPN experts Dr. Laura Michaelis, Dr. Ruben Mesa, Dr. Bart Scott and our own Andrew Schorr gathered to discuss the latest news and research in myeloproliferative neoplasms (MPNs).


Research Studies for Polycythemia Vera

From “The Conversation, MPN Edition,” Dr. Srdan Verstovsek of MD Anderson Cancer Center, Dr. Mark Heaney of Columbia University Cancer Center, and Bob Rosen, Chair of MPN Research Foundation, discuss their views on observational studies and clinical trials, as well as how polycythemia vera (PV) patients should approach participation in research studies


Could Two Be Better Than One? Clinical Trials for Combination Therapies in MPNs

Dr. Brady Stein from Northwestern Medicine discusses combination therapies for MPNs that are currently being evaluated in clinical trials. He explains the function of JAK inhibitors and their effectiveness when being combined with other therapies.


Can and Should You Participate in an MPN Clinical Trial?

Dr. Stephen Oh from the Washington University School of Medicine discusses why you should have a consultation with a specialist and the factors to consider when deciding to participate in clinical trials.


What Could a New Study REVEAL About PV Patients?

In this program, Dr. Ruben Mesa discusses a study for patients with polycythemia vera (PV), explaining the purpose of the study, who is eligible, and how the data collected could benefit patients.


Are Clinical Trials Safe? Experts Allay Your Fears

Are clinical trials safe? Leading researchers in the field dispel myths and discuss the risks and benefits of clinical trials.


Understanding Clinical Trials: What Are the Phases?

Dr. Bart Scott from Seattle Cancer Alliance and Linda Seymour, a Hematology Clinical Trials Research Nurse at City of Hope, discuss patient participation in clinical trials and explain the phases of clinical trials and their purpose


Advancing MPN Treatment Through Clinical Trials

MPN experts, Dr. Verstovsek, Dr. Ross Levine and Dr. Olatoyosi Odenike review how the development of ruxolitinib (Jakafi®) has influenced enrollment in clinical trials, the promises of combination therapy and how DNA tests will affect treatment.


Anne’s Story: Why a Clinical Trial Was Right for Me

Patient advocate, Anne, was diagnosed with polycythemia vera in 2010. She shares why she decided to participate in a clinical trial and how it’s made a difference for her.


The MPN Clinical Trials Center is sponsored by Incyte Corporation.

Page last updated on May 4, 2017